GENE MUTATIONS AND MICRORNA SIGNATURE IN MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE AND LENALIDOMIDE THERAPY

被引：0

作者：

Follo, M. Y. ^{[1
]}

Pellagatti, A. ^{[2
]}

Armstrong, R. N. ^{[2
]}

Ratti, S. ^{[1
]}

Mongiorgi, S. ^{[1
]}

Astolfi, A. ^{[3
,4
]}

Indio, V. ^{[3
]}

De Fanti, S. ^{[5
]}

Russo, D. ^{[6
]}

Gobbi, M. ^{[7
]}

Miglino, M. ^{[7
]}

Bochicchio, M. T. ^{[8
]}

Martinelli, G. ^{[9
]}

Parisi, S. ^{[8
]}

Pession, A. ^{[4
]}

Cavo, M. ^{[8
]}

Cocco, L. ^{[1
]}

Manzoli, L. ^{[1
]}

Boultwood, J. ^{[2
]}

Finelli, C. ^{[8
]}

机构：

[1] Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Bologna, Italy

[2] Univ Oxford, John Radcliffe Hosp, Nuffield Div Clin Lab Sci, Bloodwise Mol Haematol Unit,Dept Med, Oxford, England

[3] Univ Bologna, Interdept Ctr Canc Res G Prodi, Bologna, Italy

[4] Univ Bologna, S Orsola Malpighi Hosp, Pediat Hematol & Oncol Unit, Bologna, Italy

[5] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy

[6] Univ Brescia, Chair Hematol, Unit Blood Dis & Stem Cell Transplantat, Dept Clin & Expt Sci, Brescia, Italy

[7] Univ Genoa, Dept Hematol & Oncol, Genoa, Italy

[8] Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy

[9] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, FC, Italy

来源：

HAEMATOLOGICA | 2018年 / 103卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO050

引用

页码：S43 / S44

页数：2

共 50 条

[1] Gene Mutations and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy
Follo, Matilde Y.
Pellagatti, Andrea
Armstrong, Richard N.
Ratti, Stefano
Mongiorgi, Sara
Astolfi, Annalisa
Indio, Valentina
Clissa, Cristina
Russo, Domenico
Gobbi, Marco
Barraco, Marilena
Parisi, Sarah
Pession, Andrea
Cavo, Michele
Manzoli, Lucia
Cocco, Lucio
Boultwood, Jacqueline
Finelli, Carlo
BLOOD, 2017, 130
[2] Role of Nuclear Inositide Signalling and microRNA Signature in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy
Follo, Matilde
Mongiorgi, Sara
Clissa, Cristina
Astolfi, Annalisa
Russo, Domenico
Gobbi, Marco
Bosi, Costanza
Crugnola, Monica
Stanzani, Marta
Ratti, Stefano
Parisi, Sarah
Barraco, Marilena
Manzoli, Lucia
Pession, Andrea
Cocco, Lucio
Finelli, Carlo
BLOOD, 2016, 128 (22)
[3] Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes
Follo, Matilde Y.
Mongiorgi, Sara
De Stefano, Alessia
Indio, Valentina
Astolfi, Annalisa
Pellagatti, Andrea
Ratti, Stefano
Fogli, Miriam
Parisi, Sarah
Pession, Andrea
Cavo, Michele
Manzoli, Lucia
Cocco, Lucio
Boultwood, Jacqueline
Finelli, Carlo
BLOOD, 2020, 136
[4] Negative Prognostic Relevance of a Specific 3-Gene Cluster in Myelodysplastic Syndromes during Azacitidine and Lenalidomide Therapy
Follo, Matilde Y.
Pellagatti, Andrea
Armstrong, Richard N.
Ratti, Stefano
Mongiorgi, Sara
Astolfi, Annalisa
Indio, Valentina
Bochicchio, Maria Teresa
Clissa, Cristina
Russo, Domenico
Gobbi, Marco
Parisi, Sarah
Fogli, Miriam
Martinelli, Giovanni
Pession, Andrea
Cavo, Michele
Manzoli, Lucia
Cocco, Lucio
Boultwood, Jacqueline
Finelli, Carlo
BLOOD, 2018, 132
[5] Role of Mir-192-5p during Response to Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes
Follo, Matilde Y.
De Stefano, Alessia
Mongiorgi, Sara
Indio, Valentina
Astolfi, Annalisa
Ratti, Stefano
Pellagatti, Andrea
Fogli, Miriam
Pession, Andrea
Cavo, Michele
Manzoli, Lucia
Cocco, Lucio
Boultwood, Jacqueline
Parisi, Sarah
Paolini, Stefania
Finelli, Carlo
BLOOD, 2021, 138 : 3673 - +
[6] Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations
Wang, Xin
Xiao, Zhijian
Qin, Tiejun
Xu, Zefeng
Jia, Yujiao
Qu, Shiqiang
Li, Bing
Pan, Lijuan
Gao, Qingyan
Jiao, Meng
Gale, Robert Peter
HEMATOLOGY, 2024, 29 (01)
[7] MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia
Krejcik, Zdenek
Belickova, Monika
Hrustincova, Andrea
Votavova, Hana
Jonasova, Anna
Cermak, Jaroslav
Dyr, Jan E.
Merkerova, Michaela Dostalova
CANCER BIOMARKERS, 2018, 22 (01) : 101 - 110
[8] Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia—a wise Liaison?
U Platzbecker
U Germing
Leukemia, 2013, 27 : 1813 - 1819
[9] Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
Platzbecker, U.
Germing, U.
LEUKEMIA, 2013, 27 (09) : 1813 - 1819
[10] DEVELOPMENT OF EARLY INFECTIONS DURING AZACITIDINE THERAPY FOR HIGH- RISK MYELODYSPLASTIC SYNDROMES
Duenas, V.
Rodriguez, D.
Pardavila, E.
Arguello, M.
Rodriguez, S.
Lorenzana, N.
Luno, E.
Bernal, T.
HAEMATOLOGICA, 2014, 99 : 750 - 750

← 1 2 3 4 5 →